Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells

被引：0
|
作者：
Scopim-Ribeiro, Renata [1 ]
Machado-Neto, Joao Agostinho [1 ]
Campos, Paula de Melo [2 ]
Santos Duarte, Adriana da Silva [2 ]
Scheucher, Priscila Santos [1 ]
Goes, Amelia [1 ]
Olalla Saad, Sara Teresinha [2 ]
Simoes, Belinda Pinto [1 ]
Rego, Eduardo Magalhaes [1 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil
[2] Univ Estadual Campinas, Inst Nacl Ciencia & Tecnol Sangue, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Kimura, Akihiro
    Tanaka, Remi
    Nagayoshi, Sakiko
    Hoshida, Tadafumi
    Tanabe, Kazufumi
    Nishida, Shozo
    BMB REPORTS, 2023, 56 (02) : 78 - 83
  • [32] SEQUENTIAL ACQUISITION OF BCR-ABL1 FUSION AND IKAROS DELETION IN PHILADELPHIA CHROMOSOME POSITIVE ALL
    Cazzaniga, Giovanni
    Van Delft, Frederik W.
    Colman, Sue
    Score, Joannah
    Kempski, Helena
    Taj, Mary
    Ford, Anthony
    Biondi, Andrea
    Greaves, Mel
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 833 - 833
  • [33] RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
    Masuda, Tatsuya
    Maeda, Shintaro
    Shimada, Sae
    Sakuramoto, Naoya
    Morita, Ken
    Koyama, Asami
    Suzuki, Kensho
    Mitsuda, Yoshihide
    Matsuo, Hidemasa
    Kubota, Hirohito
    Kato, Itaru
    Tanaka, Kuniaki
    Takita, Junko
    Hirata, Masahiro
    Kataoka, Tatsuki R.
    Nakahata, Tatsutoshi
    Adachi, Souichi
    Hirai, Hideyo
    Mizuta, Shuichi
    Naka, Kazuhito
    Imai, Yoichi
    Kimura, Shinya
    Sugiyama, Hiroshi
    Kamikubo, Yasuhiko
    CANCER SCIENCE, 2022, 113 (02) : 529 - 539
  • [34] ASSESSMENT OF THE MOLECULAR DISEASE LEVEL IN PATIENTS WITH BCR-ABL1 POSITIVE CML IN DENMARK AND ICELAND
    Pallisgaard, N.
    Udby, L.
    Dufva, I. H.
    Severinsen, M. T.
    Bjerrum, O. W.
    Bergmann, O. J.
    Starklint, J.
    Ronnov-Jessen, D.
    Reykdal, S.
    Stentoft, J.
    HAEMATOLOGICA, 2016, 101 : 740 - 740
  • [35] Ikzf1 Haploinsufficiency Contributes to the Pathogenesis of BCR-ABL1 Positive Acute Lymphoblastic Leukemia.
    Collins-Underwood, Racquel
    Miller, Christopher B.
    Downing, James R.
    Mullighan, Charles G.
    BLOOD, 2009, 114 (22) : 283 - 284
  • [36] Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1
    Tomita, Osamu
    Iijima, Kazutoshi
    Ishibashi, Takeshi
    Osumi, Tomoo
    Kobayashi, Kenichiro
    Okita, Hajime
    Saito, Masahiro
    Mori, Tetsuya
    Shimizu, Toshiaki
    Kiyokawa, Nobutaka
    LEUKEMIA RESEARCH, 2014, 38 (03) : 361 - 370
  • [37] Sub-Clonal Genetic Heterogeneity in BCR-ABL1 Positive Acute Lymphoblastic Leukaemia
    Carnicer, Maria-Jose
    van Delft, Frederik W.
    Kearney, Lyndal
    Greaves, Mel
    BLOOD, 2011, 118 (21) : 593 - 593
  • [38] IKZF1 deletions are highly associated with BCR-ABL1 positive adult B-ALL
    Fasan, A.
    Haferlach, C.
    Kem, W.
    Haferlach, T.
    Schnittger, S.
    ONKOLOGIE, 2013, 36 : 182 - 182
  • [39] Sequential acquisition of BCR-ABL1 fusion and IKAROS deletion in Philadelphia chromosome positive ALL
    van Delft, F. W.
    Cazzaniga, G.
    Colman, S.
    Score, J.
    Lo Nigro, L.
    Taj, M.
    Ford, A.
    Biondi, A.
    Greaves, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 8 - 8
  • [40] TARGETING THE HEDGEHOG SIGNALING PATHWAY IN THERAPY-RESISTANT BCR-ABL1 POSITIVE LEUKEMIA
    Tauchi, T.
    Katagiri, S.
    Kimura, S.
    Maekawa, T.
    Ohyashiki, K.
    HAEMATOLOGICA, 2012, 97 : 207 - 207
12345